Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol

Avian Pathology

Volumn 37, Issue 1, 2008, Pages 83-88

  Devlin, J M ^a   Browning, G F ^a   Gilkerson, J R ^a   Fenton, S P ^a   Hartley, C A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GLYCOPROTEIN; INACTIVATED VACCINE; VIRUS PROTEIN; VIRUS VACCINE; WATER;

AEROSOL; ANIMAL; ANIMAL DISEASE; ARTICLE; CHICKEN; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; GENETICS; GERMFREE ANIMAL; HERPES VIRUS INFECTION; ILTOVIRUS; IMMUNOLOGY; METABOLISM; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

AEROSOLS; ANIMALS; CHICKENS; DRUG ADMINISTRATION ROUTES; GLYCOPROTEINS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; OPHTHALMIC SOLUTIONS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, INACTIVATED; VIRAL PROTEINS; VIRAL VACCINES; WATER;

GALLID HERPESVIRUS 1; GALLUS GALLUS;

EID: 38349073424     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079450701802214     Document Type: Article

References (25)

1. Alcami, A. & Koszinowski, U.H. (2000). Viral mechanisms of immune evasion. Trends in Microbiology, 8, 410-418.
2. Bagust, T.J. & Johnson, M.A. (1995). Avian infectious laryngotracheitis: virus-host interactions in relation to prospects for eradication. Avian Patholology, 24, 373-91.
3. Bagust, T.J., Jones, R.C. & Guy, J.S. (2000). Avian infectious laryngotracheitis. Revue scientifique et technique (International Office of Epizootics), 19, 483-492.
4. Bagust, T.J., Fenton, S.P. & Reddy, M.R. (2004). Detection of subgroup J avian leukosis virus infection in Australian meat-type chickens. Australian Veterinary Journal, 82, 701-706.
5. Bryant, N.A., Davis-Poynter, N., Vanderplasschen, A. & Alcami, A. (2003). Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. The EMBO Journal, 22, 833-846.
6. Clarke, J.K., Robertson, G.M. & Purcell, D.A. (1980). Spray vaccination of chickens using infectious laryngotracheitis virus. Australian Veterinary Journal, 56, 424-428.
7. Costes, B., Ruiz-Arguello, M.B., Bryant, N.A., Alcami, A. & Vanderplasschen, A. (2005). Both soluble and membrane-anchored forms of Felid herpesvirus 1 glycoprotein G function as a broad-spectrum chemokine-binding protein. Journal of General Virology, 86, 3209-3214.
8. Devlin, J.M., Browning, G.F. & Gilkerson, J.R. (2006a). A glycoprotein I- and glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells. Archives of Virology, 151, 1281-1289.
9. Devlin, J.M., Browning, G.F., Hartley, C.A., Kirkpatrick, N.C., Mahmoundian, A., Noormohammadi, A.H. & Gilkerson, J.R. (2006b). Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. Journal of General Virology, 87, 2839-2847.
10. Devlin, J.M., Browning, G.F., Hartley, C.A. & Gilkerson, J.R. (2007). Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine, 25, 3561-3566
11. Fahey, K.J. & York, J.J. (1990) The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. Journal of General Virology, 71, 2401-2405.
12. Fuchs, W., Wiesner, D., Veits, J., Teifke, J.P. & Mettenleiter, T.C. (2005). In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. Journal of Virology, 79, 705-716.
13. Guy, J.S., & Bagust, T.J. (2003). Laryngotracheitis. In: Y.M. Saif, H.J. Barnes, J.R. Glisson, A.M. Fadly, L.R. McDougald & D.E. Swayne (Eds.), Diseases of Poultry 11th edn (pp. 121-134). Ames: Iowa State Press.
14. Guy, J.S., Barnes, H.J. & Morgan, L.M. (1990). Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Diseases, 34, 106-113.
15. Guy, J.S., Barnes, H.J. & Smith, L. (1991). Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Diseases, 35, 348-355.
16. Han, M.G., Kweon, C.H., Mo, I.P. & Kim, S.J. (2002). Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene. Archives of Virology, 147, 1017-1031.
17. Helferich, D., Veits, J., Teifke, J.P., Mettenlieter, T.C. & Fuchs, W. (2007). The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. Journal of General Virology, 88, 732-742.
18. Jordan, F.T.W. (1981). Immunity to infectious laryngotracheitis. In: M.E. Ross, L.N. Payne & B.M. Freeman (Eds.), Avian Immunology (pp. 245-254). Edinburgh: British Poultry Science Ltd.
19. Kawaguchi, T., Nomura, K., Hirayama, Y. & Kitagawa, T. (1987). Establishment and characterization of a chicken hepato-cellular carcinoma cell line, LMH. Cancer Research, 47, 4460-4464.
20. Kirkpatrick, N.C., Mahmoudian, A., Colson, C.A., Devlin, J.M. & Noormohammadi, A.H. (2006). Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis. Avian Pathology, 35, 449-453.
21. Kongsuwan, K., Johnson, M.A., Prideaux, C.T. & Sheppard, M. (1993). Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32 kilodaltons. Virus Research, 29, 125-140.
22. Purcell, D.A. & Surman, P.G. (1974). Aerosol administration of the SA-2 vaccine strain of infectious laryngotracheitis virus. Australian Veterinary Journal, 50, 419-420.
23. Robertson, G.M. & Egerton, J.R. (1981). Replication of infectious laryngotracheitis virus in chickens following vaccination. Australian Veterinary Journal, 57, 119-123.
24. Schnitzlein, W.M., Winans, R., Ellsworth, S. & Tripathy, D.N. (1995). Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology, 209, 304-314.
25. Veits, J., Luschow, D., Kindermann, K., Werner, O., Teifke, J.P., Mettenleiter, T.C. & Fuchs, W. (2003). Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. Journal of General Virology, 84, 3343-3352.